Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to ...
MyChesCo on MSN
FDA escalates drug crackdown while advancing new policies
WASHINGTON, D.C. — The Food and Drug Administration this past week took several actions that could affect patients, ...
Investing.com-- U.S. private equity giant KKR (NYSE:KKR) is exploring a multibillion-dollar sale of data centre cooling ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果